miRNA polymorphisms and risk of premature coronary artery disease

Mozaffarian, 2016, American Heart Association Statistics Committee;Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association, Circulation, 133 Hajar, 2017, Risk Factors for Coronary Artery Disease: Historical Perspectives, Heart Views, 18, 109, 10.4103/HEARTVIEWS.HEARTVIEWS_106_17 Tousoulis, 2019, Novel risk factors in coronary artery disease: are they clinically relevant?, Hellenic J Cardiol, 60, 149, 10.1016/j.hjc.2019.06.003 Papageorgiou, 2018, Single-nucleotide polymorphisms and their role in coronary artery disease: Where do we stand now?, Hellenic J Cardiol, 59, 14, 10.1016/j.hjc.2018.02.013 Zdravkovic, 2002, Heritability of death from coronary heart disease: A 36-year follow-up of 20 966 Swedish twins, J Intern Med, 252, 247, 10.1046/j.1365-2796.2002.01029.x Esteller, 2011, Non-coding RNAs in human disease, Nat Rev Genet, 12, 861, 10.1038/nrg3074 Sun, 2009, SNPs in human miRNA genes affect biogenesis and function, RNA, 15, 1640, 10.1261/rna.1560209 Ryan, 2017, microRNAs in Cancer Susceptibility, Adv Canc Res, 135, 151, 10.1016/bs.acr.2017.06.004 Wang, 2019, Genetic variants in microRNAs are associated with cervical cancer risk, Mutagenesis, 34, 127, 10.1093/mutage/gez005 Srivastava, 2018, Single nucleotide polymorphisms of microRNA in cardiovascular diseases, Clin Chim Acta, 478, 101, 10.1016/j.cca.2017.12.037 Liu, 2017, Significant association between functional microRNA polymorphisms and coronary heart disease susceptibility: a comprehensive meta-analysis involving 16484 subjects, Oncotarget, 8, 5692, 10.18632/oncotarget.14249 Mendis, 2011, Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. World Health Organization definition of myocardial infarction: 2008-09 revision, Int J Epidemiol, 40, 139, 10.1093/ije/dyq165 Yan, 2019, microRNAs in Cardiovascular Disease: Small Molecules but Big Roles, Curr Top Med Chem, 10.2174/1568026619666190808160241 Bhartiya, 2011, miRvar: A comprehensive database for genomic variations in microRNAs, Hum Mutat, 32, E2226, 10.1002/humu.21482 Louridas, 2019, The limited role of genetics explaining the atherosclerotic process and coronary artery disease and the holistic perspective of systems biology, Hellenic J Cardiol, 60, 141, 10.1016/j.hjc.2018.06.002 Wu, 2013, The human MTHFR rs4846049 polymorphism increases coronary heart disease risk through modifying miRNA binding, Nutr Metabol Cardiovasc Dis, 23, 693, 10.1016/j.numecd.2012.02.009 Gazzar, 2011, MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-α during TLR4-induced gene reprogramming, J Leukoc Biol, 90, 509, 10.1189/jlb.0211074 Luthra, 2008, MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of annexin A1 downregulation in cancers, Oncogene, 27, 6667, 10.1038/onc.2008.256 Sung, 2016, miRNA polymorphisms (miR-146a, miR-149, miR-196a2 and miR-499) are associated with the risk of coronary artery disease, Mol Med Rep, 14, 2328, 10.3892/mmr.2016.5495 Xiong, 2014, A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression, Mutat Res, 761, 15, 10.1016/j.mrfmmm.2014.01.001 Ramkaran, 2014, miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease, Cell Biochem Biophys, 68, 259, 10.1007/s12013-013-9704-7 Yang, 2012, Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population, Hum Immunol, 73, 101, 10.1016/j.humimm.2011.10.005 Bastami, 2019, miRNA Polymorphisms and Risk of Cardio-Cerebrovascular Diseases: A Systematic Review and Meta-Analysis, Int J Mol Sci, 20, E293, 10.3390/ijms20020293